SEARCH

SEARCH BY CITATION

References

  • Adamsson, M., Fallgren, B. & Edvinsson, L. (1992). Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-trisphosphate). Br. J. Pharmacol., 105, 9396.
  • Aksoy, M.O., Harakal, C., Smith, J.B., Stewart, G.J. & Zerweck, C.R. (1990). Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation. Br. J. Pharmacol., 99, 461466.
  • Aldasoro, M., Martinez, C., Vila, J.M., Flor, B. & Lluch, S. (1993). Endothelium-dependent component in the contractile responses of human omental arteries to adrenergic stimulation. Eur. J. Pharmacol., 250, 103107.
  • Altiere, R.J., Kiritsy-Roy, J.A. & Catravas, J.D. (1986). Acetylcholine-induced contractions in isolated rabbit pulmonary arteries: role of thromboxane A2. J. Pharmacol. Exp. Ther., 236, 535541.
  • Andriantsitohaina, R. & Stoclet, J.C. (1988). Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries. Br. J. Pharmacol., 95, 419428.
  • Andriantsitohaina, R., Andre, P. & Stoclet, J.C. (1990). Pertussis toxin abolishes the effect of neuropeptide Y on rat resistance arteriole contraction. Am. J. Physiol., 259, H1427H1432.
  • Andriantsitohaina, R., Bian, K., Stoclet, J.C. & Bukoski, R.D. (1993). Neuropeptide Y increases force development through a mechanism that involves calcium entry in resistance arteries. J. Vasc. Res., 30, 309314.
  • Budai, D., Vu, H.Q. & Duckles, S.P. (1989). Endothelium removal does not affect potentiation by neuropeptide Y in rabbit ear artery. Eur. J. Pharmacol., 168, 97100.
  • Buzzard, C.J., Pfister, S.L. & Campbell, W.B. (1993). Endothelium-dependent contractions in rabbit pulmonary artery are mediated by thromboxane A2. Circ. Res., 72, 10231034.
  • Campos, A.H. & Calixto, J.B. (1994). Mechanisms involved in the contractile responses of kinins in rat portal vein rings: mediation by B1 and B2 receptors. J. Pharmacol. Exp. Ther., 268, 902909.
  • Chester, A.H., Allen, S.P., Tadjkarimi, S. & Yacoub, M.H. (1993). Interaction between thromboxane A2 and 5-hydroxy-tryptamine receptor subtypes in human coronary arteries. Circulation, 87, 874880.
  • Clozel, M., Breu, V., Gray, G.A., Kalina, B., Loffler, B.M., Burri, K., Cassal, J.M., Hirt, G., Muller, M., Neidhart, W. & Ramuz, H. (1994). Pharmacological characterization of Bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228235.
  • Cocks, T.M., Kemp, B.K., Pruneau, D. & Angus, J.A. (1993). Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Br. J. Pharmacol., 110, 360368.
  • Daly, R.N. & Hieble, J.P. (1987). Neuropeptide Y modulates adrenergic neurotransmission by an endothelium dependent mechanism. Eur. J. Pharmacol., 138, 445446.
  • Descombes, J.-J., Devys, M., Laubie, M. & Verbeuren, T.J. (1993). Endothelial thromboxane production plays a role in the contraction caused by 5-hydroxytryptamine in rat basilar arteries. Eur. J. Pharmacol., 243, 193199.
  • Duckles, S.P. & Buxton, I.L.O. (1994). Neuropeptide Y potentiates norepinephrine-stimulated inositol phosphate production in the rat tail artery. Life Sci., 55, 103109.
  • Edvinsson, L., Ekblad, E., Hakanson, R. & Wahlestedt, C. (1984). Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br. J. Pharmacol., 83, 519525.
  • Edvinsson, L., Hakanson, R., Wahlestedt, C. & Uddman, R. (1987). Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol. Sci., 8, 231235.
  • Fabi, F., Argiolas, L., Chiavarelli, M. & Del Basso, P. (1996). Nitric oxide-dependent and-independent modulation of sympathetic vasoconstriction in the human saphenous vein. Eur. J. Pharmacol., 309, 4150.
  • Fabi, F., Chiavarelli, M., Argiolas, L., Chiavarelli, R. & Del Basso, P. (1993). Evidence for sympathetic neurotransmission through presynaptic N-type calcium channels in human saphenous vein. Br. J. Pharmacol., 110, 338342.
  • Furchgott, R.F. & Vanhoutte, P.M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J., 3, 20072018.
  • Gustafsson, H. & Nilsson, H. (1990). Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit. Acta Physiol. Scand., 138, 503507.
  • Hieble, J.P., Duesler, J.G. & Daly, R.N. (1989). Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation. J. Pharmacol. Exp. Ther., 250, 523528.
  • Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K. & Masaki, T. (1989). The human endothelin family: three structurally and pharmacologically distinct isopep-tides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A., 86, 28632867.
  • Katusic, Z.S., Shepherd, J.T. & Vanhoutte, P.M. (1988). Endothelium-dependent contractions to calcium ionophore A23187, arachidonic acid and acetylcholine in canine basilar arteries. Stroke, 19, 476479.
  • Li, K., Sirois, P. & Rouleau, J.L. (1994). Role of endothelial cells in cardiovascular function. Life Sci., 54, 579592.
  • Lin, P.J., Chang, C.H., Pearson, P.J., Tzen, K.Y., Chu, J.J., Chang, J.P. & Hsieh, M.J. (1993). Thromboxane A2: an endothelium-derived vasoconstrictor in human internal mammary arteries. Ann. Thorac. Surg., 56, 97100.
  • Lundberg, J.M., Hemsen, A., Larsson, O., Rudehill, A., Saria, A. & Fredholm, B.B. (1988). Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium inhibition of vasoconstriction. Eur. J. Pharmacol., 145, 2130.
  • Luu, T.N., Chester, A.H., O'Neil, G.S., Tadikarimi, S. & Yacoub, M.H. (1992). Effects of vasoactive neuropeptides on human saphenous vein. Br. Heart J., 67, 474477.
  • Macho, P., Perez, R., Huidobro-Toro, J.P. & Domenech, R.J. (1989). Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction. Eur. J. Pharmacol., 167, 6774.
  • Marsault, R., Illiano, S. & Vanhoutte, P.M. (1997). Bradykinin-induced contractions of canine saphenous veins: mediation by B2 receptors and involvement of eicosanoids. Br. J. Pharmacol., 120, 215220.
  • Mckenniff, M.G., Norman, P., Cuthbert, N.J. & Gardiner, P.J. (1991). Bay u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Br. J. Pharmacol, 104, 585590.
  • Norel, X., Labat, C., Gardiner, P.J. & Brink, C. (1991). Inhibitory effects of Bay u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations. Br. J. Pharmacol., 104, 591595.
  • Oellerich, W.F. & Malik, K.U. (1993). Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther., 266, 13211329.
  • Ogletree, M.L., Harris, D.N., Schumacher, W.A., Webb, M.L. & Misra, R.N. (1993). Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. J. Pharmacol. Exp. Ther., 264, 570578.
  • Parry, M.J., Randall, M.J., Hawkeswood, E., Cross, P.E. & Dickinson, R.P. (1982). Enhanced production of prostacyclin in blood after treatment with selective thromboxane synthetase inhibitor, UK-38,484. Br. J. Pharmacol., 75, Suppl., 547 P.
  • Pernow, J., Saria, A. & Lundberg, J.M. (1986). Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol. Scand., 126, 239249.
  • Potter, E.K. (1988). Neuropeptide Y as an autonomic neurotransmitter. Pharmacol. Ther., 37, 251273.
  • Prieto, D., Simonsen, U. & Nyborg, N.C.B. (1995). Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries. Br. J. Pharmacol., 116, 27292737.
  • Saville, V.L., Maynard, K.I. & Burnstock, G. (1990). Neuropeptide Y potentiates purinergic as well as adrenergic responses of the rabbit ear artery. Eur. J. Pharmacol., 176, 117125.
  • Small, D.L., Bolzon, B.J. & Cheung, D.W. (1992). Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery. Eur. J. Pharmacol., 210, 131136.
  • Vanhoutte, P.M., Luscher, T.F. & Graser, T. (1991). Endothelium-dependent contractions. Blood Vessels, 28, 7483.
  • Vu, H.Q., Budai, D. & Duckles, S.P. (1989). Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction. J. Pharmacol. Exp. Ther., 251, 852857.
  • Wahlenstedt, C., Edvinsson, L., Ekblad, E. & Hakanson, R. (1985). Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J. Pharmacol. Exp. Ther., 234, 735741.
  • Westfall, T.C., Yang, C.L. & Curfman-Falvey, M. (1995). Neuropeptide Y-ATP interactions at the vascular sympathetic neuroeffector junction. J. Cardiovasc. Pharmacol., 26, 682687.
  • Winer, B.J. (1971). Statistical Principles In Experimental Design. 514603. New York : McGraw-Hill Book Company.
  • Wong-Dusting, H.J. & Rand, M.J. (1988). Pre- and postjunctional effects of neuropeptide Y on the rabbit isolated ear artery. Clin. Exp. Pharmacol. Physiol., 15, 411418.
  • Yanagisawa, M., Kurihara, H., Kumura, S., Tomobe, Y., Kobayashi, M., Mitsui, T., Yasaki, Y., Goto, K. & Masaki, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411415.
  • Yang, Z., Richard, V., Von Segesser, L., Bauer, E., Stulz, P., Turina, M. & Luscher, F. (1990). Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. Circulation, 82, 188195.
  • Yang, Z., Von Segesser, L., Bauer, E., Stulz, P., Turina, M. & Luscher, T.F. (1991). Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ. Res., 68, 5260.